公众号 / 文章重症综合管理与镇静镇痛中毒与环境急症

急诊科重度急性行为障碍肠外镇静的最佳方法

What is the best approach for parenteral sedation to manage severe acute behavioral disturbance in the emergency department?
PubMed 文献 · Clin Toxicol (Phila) · 2025-12-08
一句话结论作者推荐肌注氟哌利多(无氟哌利多时用奥氮平)作为重度急性行为障碍一线镇静,15分钟未达有效镇静可重复,需救援或极危险时用氯胺酮,不常规推荐苯二氮䓬类,不推荐联合治疗。

该文为急诊科重度急性行为障碍肠外镇静的循证方法学文章。作者指出急诊最常见病因为酒精和药物中毒,镇静目标是安全观察至中毒作用消退并争取检查治疗时间。推荐首选肌注途径(除非已有静脉通路),首选氟哌利多或奥氮平为一线药物,需救援或极危险时用氯胺酮,不常规推荐苯二氮䓬类(除非酒精戒断或兴奋剂中毒等特定病因),不推荐抗精神病药联合苯二氮䓬类。镇静后所有患者均需密切观察,至少定期监测生命体征、镇静水平及不吸氧下连续脉搏血氧,有条件时用呼气末二氧化碳监测。

要点

  • 作者推荐肌注氟哌利多(无氟哌利多时用奥氮平)作为重度急性行为障碍一线镇静,因有效性和安全性证据强。
  • 作者推荐肌注氟哌利多15分钟未达有效镇静可重复给药。
  • 需救援镇静或极危险需立即控制时,作者推荐氯胺酮。
  • 作者不常规推荐苯二氮䓬类(如咪达唑仑)作为一线,除非酒精戒断或兴奋剂中毒等特定病因。
  • 作者不推荐抗精神病药与苯二氮䓬类联合治疗,因不良反应增加而无明确疗效增加证据。

适用人群与场景

  • 急诊科重度急性行为障碍患者。
  • 急诊最常见病因为酒精和药物中毒,两者相对短暂。

诊断标准与关键阈值

  • 可使用经过验证的评分工具(如镇静评估工具评分)指导行为障碍的客观评估。

处置流程与药物剂量

  • 首选肌注途径,除非已有静脉通路(如急救人员已建立),因可快速给药且所需身体约束较少。
  • 一线首选肌注氟哌利多;无氟哌利多时用奥氮平。
  • 肌注氟哌利多15分钟未达有效镇静可重复给药。
  • 需救援镇静或极危险需立即控制时,用氯胺酮。
  • 不常规推荐苯二氮䓬类(如咪达唑仑),除非治疗对苯二氮䓬类反应良好的特定躁动病因,如酒精戒断或兴奋剂中毒。
  • 不推荐抗精神病药与苯二氮䓬类联合治疗,因不良反应增加而无明确疗效增加证据。
  • 镇静后所有患者均需密切观察,至少定期监测生命体征、镇静水平及不吸氧下连续脉搏血氧;有条件时使用呼气末二氧化碳监测。

研究设计与关键结果

  • 本文为循证方法学文章,描述急诊科重度急性行为障碍肠外镇静的处理方法,未报告原始研究样本量或效应量。

证据类型、等级与局限

  • 证据类型:综述/专家方法学文章,基于作者所述的良好证据基础。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者推荐急诊重度急性行为障碍采用标准化肠外镇静流程:肌注氟哌利多(或奥氮平)一线,15分钟可重复,需救援或极危险时用氯胺酮。
  • 作者不常规推荐苯二氮䓬类作为一线,除非酒精(或镇静催眠药)戒断或兴奋剂中毒等特定病因。
  • 作者不推荐抗精神病药与苯二氮䓬类联合治疗。
  • 镇静后所有患者均需密切观察,至少定期监测生命体征、镇静水平及不吸氧下连续脉搏血氧,有条件时用呼气末二氧化碳监测。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Patients with severe acute behavioural disturbance commonly present to the emergency department. Differing expert opinion dominates treatment strategies. We describe an evidence-based approach to parenteral sedation for the management of emergency department patients with severe acute behavioural disturbance.

APPROACH TO MANAGING SEVERE ACUTE BEHAVIOURAL DISTURBANCE WITH PARENTERAL SEDATION: The most common cause of severe acute behavioural disturbance in the emergency department setting is alcohol and drug intoxication, both being relatively short-lived. The goal of parenteral sedation is to provide safe observation until the effect of any intoxication wears off and allow time for further clinical investigation and treatment as required. A validated scoring tool, such as the sedation assessment tool score, is useful to guide objective assessment of behavioural disturbance. We recommend the intramuscular route initially, unless intravenous access is already available (i.e., placed by first responders), as it allows rapid administration and requires less physical restraint. We recommend droperidol, or olanzapine where droperidol is unavailable, as the preferred first-line parenteral agent, due to strong evidence of effectiveness and safety. When rescue therapy is required or in extremely dangerous circumstances, we recommend using ketamine. We do not routinely recommend benzodiazepines, such as midazolam, except for treating specific causes of agitation which respond well to benzodiazepines, such as alcohol withdrawal or stimulant intoxication. We recommend avoiding combination therapy (antipsychotic and benzodiazepine) due to an increased adverse effect profile, without clear evidence for increased effectiveness.

MONITORING FOLLOWING SEDATION FOR ACUTE BEHAVIOURAL DISTURBANCE: Following sedation, we recommend close observation in all patients, including at a minimum regular monitoring of vital signs, level of sedation, and continuous pulse oximetry without supplemental oxygen. End-tidal carbon dioxide monitoring should be used when available.

CONCLUSIONS: There is a good evidence base to recommend a standardized approach to the management of severe acute behavioural disturbance in the emergency department. We recommend using intramuscular droperidol (or olanzapine if droperidol is not available) as a first-line therapy, which can be repeated at 15 min if effective sedation is not achieved. If rescue sedation is required or in extremely dangerous scenarios when immediate control is required, we recommend ketamine. We do not routinely recommend benzodiazepines as first-line therapy, unless specifically treating a condition likely to benefit from benzodiazepines, such as alcohol (or sedative hypnotic) withdrawal or stimulant intoxication. We do not recommend combination therapy (antipsychotic and benzodiazepines).

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Isoardi KZ, Cole JB, Hoffman RS, et al. What is the best approach for parenteral sedation to manage severe acute behavioral disturbance in the emergency department? Clin Toxicol (Phila). 2025. PMID: 41355751. doi:10.1080/15563650.2025.2591356

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。